News About the Dean

Patient-Centered Health Education: A Conversation with Dr. Aditee Narayan

Aditee Narayan, MD, MPH, vice dean for medical and health professions education at Duke, shares her vision for transforming health care through patient-centered, interdisciplinary health care professions education. From curriculum design to clinical innovation, Dr. Narayan reminds us that educating the next generation is not just a responsibility — it’s an opportunity to shape the future of health.

Duke Health Integration: A Conversation with DHIP President Matt Barber, MD

In this conversation, Dean Klotman and Matthew Barber, MD, president of the Duke Health Integrated Practice (DHIP) and vice dean for clinical affairs, reflect on DHIP’s two-year anniversary. They highlight its role in unifying Duke Health’s clinical, academic, and community missions.

Philanthropy in Action: A Conversation with Dr. Manesh Patel

Dean Klotman and Manesh Patel, MD discuss the transformative role of philanthropy in advancing cardiovascular research and care at Duke. Their conversation highlights how the university's recent MADE FOR THIS fundraising campaign is fueling innovation, collaboration, and purpose-driven support to shape the future of heart health.

Navigating Government Relations: A Conversation with Catherine Liao

Watch Dean Klotman’s interview with Catherine Liao, Vice President of Duke Health Government Relations. In their conversation, they explore the team's strategic approach to fostering strong relationships with local, state, and national governmental entities, crucial for advancing Duke Health's missions.

The Deans: Mary E. Klotman, BS'76, MD'80, HS'80-'85

Mary E. Klotman, BS’76, MD’80, HS’80-85, is Executive Vice President for Health Affairs at Duke University, Dean of Duke University School of Medicine, and Chief Academic Officer for Duke University Health System. She was appointed dean in 2017, after serving for seven years as chair of the Department of Medicine, and re-appointed in 2022.

Looking Back, Moving Forward: Duke University School of Medicine 2024 Year in Review

From pursuing climate change research to enhancing the partnership with the Veteran's Administration, and advancing the groundbreaking FDA-approved drug for low-grade gliomas developed by the team at the Preston Robert Tisch Brain Tumor Center, the achievements at the Duke University School of Medicine in 2024 have been remarkable. Watch this short video that highlights these and other milestones.